Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry
Annals of the American Thoracic Society · 01.04.2023 · 20 (4) · 523-531
DOI: 10.1513/annalsats.202201-024oc ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the American Thoracic Society, online erschienen am 01.04.2023. Verfasst von Danieli B Salinas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Pulmonology, Department of Pediatrics, Children's Hospital Los Angeles, and. Hauptthemen laut MEDLINE: Cystic Fibrosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, Cystic Fibrosis Foundation, National Center for Advancing Translational Science.
Abstract (Originalsprache)
Rationale
Variants within the cystic fibrosis (CF) transmembrane conductance regulator gene, CFTR, that are of unknown significance or are categorized as non–CF causing may be observed in persons with CF. These variants are frequently detected in children with inconclusive newborn screen results and, in some cases, may be associated with a benign presentation in early childhood that progresses to a CF phenotype later in life.
Objectives
To analyze data from individuals enrolled in the U.S. Cystic Fibrosis Foundation Patient Registry who have received a diagnosis of CF and who have variants found in a population of children with a CF screen positive, inconclusive diagnosis (CFSPID).
Methods
This retrospective review analyzed registry data from individuals with a diagnosis of CF who also harbor one or more variants of interest because of their frequency within a CFSPID population and/or their interpretation as non–CF causing. Three groups were defined by the number of CF-causing variants identified (CF-Cx2, CF-Cx1, and CF-Cx0), which were reported in addition to the variant(s) of interest. Multivariate quantile regression modeling of the outcome for forced expiratory volume in 1 second (FEV1) generated a disease severity score for each person determined by six selected variables. Median scores were calculated for the three groups.
Results
Patients carrying one CF-causing variant and at least one variant of interest (CF-Cx1) had higher median disease severity scores compared with those carrying CF-Cx2, suggesting a milder phenotype (P < 0.05). However, there was no statistically significant difference in scores between CF-Cx2 and the two other groups combined (CF-Cx1 and CF-Cx0; P = 0.33). Analysis revealed that the CF-Cx1 and CF-Cx0 groups, when compared with the CF-Cx2 group, had later median diagnoses (8 years vs. newborn; P < 0.0001), lower median sweat chloride (48 mmol/L vs. 94.5 mmol/L; P < 0.0001), lower prevalence of pancreatic insufficiency (29% vs. 78%; P < 0.0001), and higher median FEV1% predicted (95% vs. 87%; P = 0.0002).
Conclusions
Individuals with CF who have specific variants frequently identified in children with CFSPID have a similar range of disease severity scores compared with those who have two CF-causing variants, but a milder phenotype overall. Variants that should be given careful scrutiny because of their high prevalence are G576A+R668C, T854T, R75Q, F1052V, R1070W, R31C, and L967S.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Pulmonology, Department of Pediatrics, Children's Hospital Los Angeles, and.
- Southern California Clinical and Translational Science Institute, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California.
- Department of Mathematics and Statistics, San Diego State University, San Diego, California.
- Department of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland; and.
- Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of California, San Diego, San Diego, California.
Förderung
- NCATS NIH HHS
- Cystic Fibrosis Foundation
- National Center for Advancing Translational Science
Zitieren
APA
Salinas, D. B., Wee, C. P., Bailey, B., Raraigh, K., & Conrad, D. (2023). Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry. Annals of the American Thoracic Society, 20(4), 523-531. https://doi.org/10.1513/annalsats.202201-024oc
Vancouver
Salinas DB, Wee CP, Bailey B, Raraigh K, Conrad D. Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry. Annals of the American Thoracic Society. 2023;20(4):523-531. doi:10.1513/annalsats.202201-024oc
BibTeX
@article{Salinas2023,
author = {Salinas, Danieli B and Wee, Choo Phei and Bailey, Barbara and Raraigh, Karen and Conrad, Douglas},
title = {Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry},
journal = {Annals of the American Thoracic Society},
year = {2023},
volume = {20},
number = {4},
pages = {523--531},
doi = {10.1513/annalsats.202201-024oc}
}
EUVIMED